Genomics

Dataset Information

Phase 1 Study of Ulixertinib (BVD 523) in Patients with Advanced Solid Malignancies


ABSTRACT: Phase 1 Study of Ulixertinib (BVD 523) in Patients with Advanced Solid Malignancies

PROVIDER: PRJNA882457 | ENA |

REPOSITORIES: ENA